N-(2-Benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine (6, σ(1)K(i)=2.6 nM) was radiolabeled with fluorine-18 to provide a potential σ(1) receptor radioligand for use in positron emission tomography (PET). Radiofluorination of the appropriate tosylate precursor furnished [(18)F]6 with a specific activity of 45 GBq/μmol, in an average radiochemical yield of 18% and greater than 98% radiochemical purity. MicroPET imaging in Papio hamadryas baboon brain revealed [(18)F]6 uptake consistent with σ receptor distribution, and specificity for σ receptors was demonstrated in a haloperidol pre-treated animal. [(18)F]6 possesses suitable properties for PET imaging of σ(1) receptors, and further investigation of this σ(1) receptor tracer is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2011.09.028DOI Listing

Publication Analysis

Top Keywords

σ1 receptor
12
pet imaging
8
synthesis vivo
4
vivo evaluation
4
evaluation [18f]n-2-benzofuranylmethyl-n'-[4-2-fluoroethoxybenzyl]piperazine
4
[18f]n-2-benzofuranylmethyl-n'-[4-2-fluoroethoxybenzyl]piperazine novel
4
σ1
4
novel σ1
4
receptor
4
receptor pet
4

Similar Publications

Article Synopsis
  • This study examines the tolerance development to opioids, focusing on fentanyl and a new μ-opioid receptor agonist, NFEPP, which is activated in acidic environments typical of inflammation.
  • Researchers conducted tests on mice with colitis to assess the analgesic effects and tolerance of both opioids over five days.
  • Results showed that while fentanyl led to tolerance and cross-tolerance, NFEPP did not, suggesting it could offer pain relief without the risk of escalating dosages and increased side effects.
View Article and Find Full Text PDF

Introduction: Oxysterol-binding protein (OSBP) is known for its crucial role in lipid transport, facilitating cholesterol exchange between the Golgi apparatus and endoplasmic reticulum membranes. Despite its established function in cellular processes, its involvement in coronavirus replication remains unclear.

Methods: In this study, we investigated the role of OSBP in coronavirus replication and explored the potential of a novel OSBP-binding compound, ZJ-1, as an antiviral agent against coronaviruses, including SARS-CoV-2.

View Article and Find Full Text PDF

Activin signaling is essential for proper embryonic, skeletal muscle, and reproductive development. Duplication of the pathway in teleost fish has enabled diversification of gene function across the pathway but how gene duplication influences the function of activin signaling in non-mammalian species is poorly understood. Full characterization of activin receptor signaling pathway expression was performed across embryonic development and during early skeletal muscle growth in rainbow trout (RBT, Oncorhynchus mykiss).

View Article and Find Full Text PDF

Purpose: Extracellular heat shock protein 90 AA1(eHSP90α) is intricately linked to tumor progression and prognosis. This study aimed to investigate the difference in the value of eHSP90α in post-treatment response assessment and prognosis prediction between exon 19 deletion(19DEL) and exon 21 Leu858Arg(L858R) mutation types in lung adenocarcinoma(LUAD).

Methods: We analyzed the relationship between the expression of eHSP90α and clinicopathological features in 89 patients with L858R mutation and 196 patients with 19DEL mutation in LUAD.

View Article and Find Full Text PDF

Traditional treatments of cancer have faced various challenges, including toxicity, medication resistance, and financial burdens. On the other hand, bioactive phytochemicals employed in complementary alternative medicine have recently gained interest due to their ability to control a wide range of molecular pathways while being less harmful. As a result, we used a network pharmacology approach to study the possible regulatory mechanisms of active constituents of for the treatment of liver cancer (LC).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!